SEC Form 4 · accession 0000920465-15-000068
LA JOLLA PHARMACEUTICAL CO · LJPC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George F Tidmarsh
Officer — President, CEO & Secretary · Director
Period of report
Aug 31, 2015
Accepted (ET)
Sep 2, 2015 · 9:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $35.58 | Aug 31, 2015 | A | 40,000 | A | — | Aug 31, 2025 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1Option vests and becomes exercisable upon the achievement of certain performance-related goals in 2016. The timing for the achievement of such goals determines the number of shares underlying the award.
- F2Represents the maximum number of shares of common stock underlying the option grant, with the actual number of shares issuable upon exercise to be determined based on the timing of the achievement of the vesting criteria described in footnote 1.